Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03105336
Title A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications

follicular lymphoma

non-Hodgkin lymphoma

Therapies

axicabtagene ciloleucel

Age Groups: senior | adult
Covered Countries USA | FRA


No variant requirements are available.